Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments
Open Access
- 19 November 2009
- journal article
- review article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 17 (4) , 374-379
Abstract
Imaging studies play a crucial role in the diagnosis and staging of hepatocellular carcinoma (HCC). Yet, assessment of tumor response is another important goal for imaging. The imaging techniques most commonly used for assessing tumor response include computed tomography and magnetic resonance imaging. Imaging modalities and imaging criteria vary according to the treatment (surgical resection and transplantation or nonsurgical treatments such as transarterial chemoembolization, radiofrequency ablation, and molecular targeted therapy). Efficacy of nonsurgical treatments for malignancy is usually evaluated with RECIST criteria. These criteria, based on tumor shrinkage, are often inappropriate in HCCs. The response criteria should take into account tumor necrosis induced by treatment. Today, tumor necrosis is estimated by a disappearance of hypervascularization on contrast‐enhanced imaging. New tools such as functional imaging (perfusion imaging, diffusion‐weighted MR imaging) could be of major importance. In this article, we present a summary of the most recent information on the role of imaging in assessing treatment efficacy in HCCs.Keywords
This publication has 33 references indexed in Scilit:
- Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenibBMC Cancer, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?Hepatology, 2007
- Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?HPB, 2007
- Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: A case-control studyLiver Transplantation, 2007
- Phase II Study of Sorafenib in Patients With Advanced Hepatocellular CarcinomaJournal of Clinical Oncology, 2006
- Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation – a clinical and histological examinationClinical Transplantation, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001